You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas: Respiratory
5 December 2023 - London-based life science company ValiRx Plc (AIM: VAL) on Tuesday announced an exclusive Option Agreement through its joint venture, ValiSeek Limited, to license VAL401 to Ambrose H...
5 December 2023 - Liquid biopsy company ANGLE plc (AIM:AGL) ( OTCQX:ANPCY) announced on Tuesday that it introduced its Portrait+ CTC staining kit at the San Antonio Breast Cancer Symposium (SABCS). Th...
Dupixent shows significant COPD exacerbation reduction in Phase 3 trial, accelerating FDA submission
27 November 2023 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) reported on Monday that Dupixent (dupilumab) demonstrated a substantial 34% reduction in chronic obstructive ...
27 November 2023 - GenFleet Therapeutics, a China-based clinical-stage biotechnology company, announced on Friday that the New Drug Application (NDA) for GFH925 (IBI351) has been accepted by the Cente...
24 November 2023 - Broncus (2216.HK), a US-based medical device company in the field of interventional pulmonology, announced on Thursday that its wholly owned subsidiary, Broncus Hangzhou has signed ...
24 November 2023 - Innovent Biologics, Inc. (HKEX: 01801), a China-based biopharmaceutical company, announced on Thursday that the Center for Drug Evaluation (CDE) of the National Medical Products Adm...
Related Headlines
Innovent and AnHeart announce acceptance of NDA for taletrectinib in China
Chiesi Farmaceutici signs Licensing Agreement with Haisco Pharmaceutical
Biodesix enhances Nodify Lung testing with Tasso+ blood draw method
Telix signs exclusive Nordic distribution deal for Illuccix with Wiik Pharma